Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Bermudez

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Drug Discovery Today|July 16, 2016
More than a look into a crystal ball: protein structure elucidation guided by molecular dynamics simulationsMarcel Bermudez, Jeremie Mortier, Christin Rakers, et al.
Molecules (Basel, Switzerland)|May 6, 2020
Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt<sup>1</sup>]DALDA, and KGOP01, Binding to the mu Opioid ReceptorMaria Dumitrascuta, Marcel Bermudez, Steven Ballet, et al.
International Journal of Molecular Sciences|February 13, 2025
Stereoselective Synthesis and Biological Evaluation of Perhydroquinoxaline-Based κ Receptor AgonistsJonathan Hoffmann, Dirk Schepmann, Constantin Daniliuc, et al.
Frontiers in Endocrinology|May 8, 2023
Editorial: Peptide-binding GPCRs coming of ageAntonella Di Pizio, Marcel Bermudez, Chris De Graaf, et al.
Drug Discovery Today|June 23, 2021
Structural insights into understudied human cytochrome P450 enzymesDavid Machalz, Szymon Pach, Marcel Bermudez, et al.
International Journal of Molecular Sciences|January 9, 2021
Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT<sub>2B</sub> ReceptorsKatrin Denzinger, Trung Ngoc Nguyen, Theresa Noonan, et al.
Biochemical Pharmacology|November 4, 2019
The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signalingMaria Grabowski, Manuela S Murgueitio, Marcel Bermudez, et al.
European Journal of Medicinal Chemistry|July 9, 2019
Identification and characterization of a novel chemotype for human TLR8 inhibitorsDora Šribar, Maria Grabowski, Manuela S Murgueitio, et al.
Biochemical Pharmacology|April 24, 2018
Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screeningMaria Grabowski, Manuela S Murgueitio, Marcel Bermudez, et al.
Drug Discovery Today|January 24, 2015
The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexesJérémie Mortier, Christin Rakers, Marcel Bermudez, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Drug Discovery Today|July 16, 2016
More than a look into a crystal ball: protein structure elucidation guided by molecular dynamics simulationsMarcel Bermudez, Jeremie Mortier, Christin Rakers, et al.
Molecules (Basel, Switzerland)|May 6, 2020
Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt<sup>1</sup>]DALDA, and KGOP01, Binding to the mu Opioid ReceptorMaria Dumitrascuta, Marcel Bermudez, Steven Ballet, et al.
International Journal of Molecular Sciences|February 13, 2025
Stereoselective Synthesis and Biological Evaluation of Perhydroquinoxaline-Based κ Receptor AgonistsJonathan Hoffmann, Dirk Schepmann, Constantin Daniliuc, et al.
Frontiers in Endocrinology|May 8, 2023
Editorial: Peptide-binding GPCRs coming of ageAntonella Di Pizio, Marcel Bermudez, Chris De Graaf, et al.
Drug Discovery Today|June 23, 2021
Structural insights into understudied human cytochrome P450 enzymesDavid Machalz, Szymon Pach, Marcel Bermudez, et al.
International Journal of Molecular Sciences|January 9, 2021
Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT<sub>2B</sub> ReceptorsKatrin Denzinger, Trung Ngoc Nguyen, Theresa Noonan, et al.
Biochemical Pharmacology|November 4, 2019
The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signalingMaria Grabowski, Manuela S Murgueitio, Marcel Bermudez, et al.
European Journal of Medicinal Chemistry|July 9, 2019
Identification and characterization of a novel chemotype for human TLR8 inhibitorsDora Šribar, Maria Grabowski, Manuela S Murgueitio, et al.
Biochemical Pharmacology|April 24, 2018
Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screeningMaria Grabowski, Manuela S Murgueitio, Marcel Bermudez, et al.
Drug Discovery Today|January 24, 2015
The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexesJérémie Mortier, Christin Rakers, Marcel Bermudez, et al.
Pageof 6